AG0013RR

1377239-83-2 | 4H-1,3-Benzothiazin-4-one, 2-[4-(cyclohexylmethyl)-1-piperazinyl]-8-nitro-6-(trifluoromethyl)-

Chemical structure of 4H-1,3-Benzothiazin-4-one, 2-[4-(cyclohexylmethyl)-1-piperazinyl]-8-nitro-6-(trifluoromethyl)-, CAS 1377239-83-2
AG0013RR
sdsSDS
sdsCOA

Price

$0.00

WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 1377239-83-2
Catalog Number AG0013RR(AGN-PC-0WGD6Y)
Chemical Name 4H-1,3-Benzothiazin-4-one, 2-[4-(cyclohexylmethyl)-1-piperazinyl]-8-nitro-6-(trifluoromethyl)-
IUPAC Name 2-[4-(cyclohexylmethyl)piperazin-1-yl]-8-nitro-6-(trifluoromethyl)-1,3-benzothiazin-4-one
InChI InChI=1S/C20H23F3N4O3S/c21-20(22,23)14-10-15-17(16(11-14)27(29)30)31-19(24-18(15)28)26-8-6-25(7-9-26)12-13-4-2-1-3-5-13/h10-11,13H,1-9,12H2
InChI Key BJDZBXGJNBMCAV-UHFFFAOYSA-N
MDL Number MFCD28902203
Molecular Formula C20H23F3N4O3S
Molecular Weight 456.4818
SMILES C1(CCCCC1)CN1CCN(CC1)C=1SC2=C(C(N1)=O)C=C(C=C2[N+](=O)[O-])C(F)(F)F
UNII A3M1353L40
Synonyms
PBTZ169, PBTZ169, 1377239-83-2, Macozinone, PBTZ-169, UNII-A3M1353L40, A3M1353L40, 2-(4-(cyclohexylmethyl)piperazin-1-yl)-8-nitro-6-(trifluoromethyl)-4H-benzo[e][1,3]thiazin-4-one, 4H-1,3-Benzothiazin-4-one, 2-(4-(cyclohexylmethyl)-1-piperazinyl)-8-nitro-6-(trifluoromethyl)-, 4H-1,3-Benzothiazin-4-one, 2-[4-(cyclohexylmethyl)-1-piperazinyl]-8-nitro-6-(trifluoromethyl)-, Macozinone [INN], SCHEMBL6128230, CHEMBL3330226, BTZ-169, PBTZ 169;PBTZ-169, BCP18094, EX-A1013, MFCD28902203, AKOS030526001, ZINC141433347, CS-5777, SB19755, YH65042, HY-12903, 2-(4-(Cyclohexylmethyl)piperazin-1-yl)-8-nitro-6-trifluoromethyl-4H-1,3-benzothiazin-4-one, 2-[4-(cyclohexylmethyl)piperazin-1-yl]-8-nitro-6-(trifluoromethyl)-1,3-benzothiazin-4-one,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited